Literature DB >> 11926412

Defective death receptor signaling as a cause of tumor immune escape.

Lars E French1, Jürg Tschopp.   

Abstract

Death receptors are a subgroup of TNF-receptor family members that can trigger caspase-8 activation and apoptosis upon interaction with their selective ligands. One of the death receptors, Fas (CD95) and its ligand is critically involved in the regulation of immune homeostasis and effectorfunction. Fas-mediated cell death is a major pathway of cytolytic T-cell-mediated death that is involved in specific killing of tumor cells. Recent investigations summarized herein have shown that defective Fas-signaling due to receptor downregulation or dysfunction, or intracellular inhibition by FLIP (FLICE inhibitory protein) can interfere with Fas-mediated tumor cell death, and thereby favor tumor immune escape.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926412     DOI: 10.1006/scbi.2001.0405

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  21 in total

1.  The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Authors:  Magda Stumpfova; Desirée Ratner; Edward B Desciak; Yehuda D Eliezri; David M Owens
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

Authors:  German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2006

3.  High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.

Authors:  Yi-Ting Chen; Hung-Pei Tsai; Chun-Chieh Wu; Chiao-Yun Chen; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Pathol Oncol Res       Date:  2018-06-09       Impact factor: 3.201

4.  Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.

Authors:  Tong Xu; Bao-Cun Sun; Qiang Li; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

5.  CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.

Authors:  Lingbing Tan; Chaocan Zhang; Julien Dematos; Linlin Kuang; Jae U Jung; Xiaozhen Liang
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 6.  Cellular FLICE-inhibitory protein: an attractive therapeutic target?

Authors:  Olivier Micheau
Journal:  Expert Opin Ther Targets       Date:  2003-08       Impact factor: 6.902

7.  Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Exp Cell Res       Date:  2006-02-17       Impact factor: 3.905

8.  The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.

Authors:  Mala Chakraborty; Elizabeth K Wansley; Jorge A Carrasquillo; Sarah Yu; Chang H Paik; Kevin Camphausen; Michael D Becker; William F Goeckeler; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 9.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.

Authors:  Shruti M Raja; Shuzhen Chen; Ping Yue; Timothy M Acker; Benjamin Lefkove; Jack L Arbiser; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.